Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
To improve the prognosis of metastatic TNBC patients, antibodydrug conjugates (ADCs), such as sacituzumab govitecan, have been utilized to specifically deliver potent chemotherapy agents directly to cancer cells expressing targeted antigens, demonstrating promising efficacy [25]
Chandra, D
Moderate risk: 28 to 48 U/L for men, 18 to 26 U/L for women
Sharma A, Porterfield JE, Smith E, Sharma R, Kannan S, Kannan RM
US$ 20.59
US$ 24.87
US$ 29.78
US$ 20.03
US$ 20.71
US$ 22.71
US$ 22.05
US$ 24.77
US$ 29.09
US$ 22.73
